Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.61B |
| 2 |
Microsoft
MSFT
|
+$1.17B |
| 3 |
Broadcom
AVGO
|
+$366M |
| 4 |
Merck
MRK
|
+$343M |
| 5 |
Meta Platforms (Facebook)
META
|
+$260M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$609M |
| 2 |
CMA
Comerica
CMA
|
+$512M |
| 3 |
CADE
Cadence Bank
CADE
|
+$422M |
| 4 |
Johnson & Johnson
JNJ
|
+$331M |
| 5 |
Western Digital
WDC
|
+$277M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.81% |
| 2 | Financials | 17.07% |
| 3 | Industrials | 12.54% |
| 4 | Consumer Discretionary | 10.14% |
| 5 | Healthcare | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2876
loanDepot
LDI
$548M
| $822K | ﹤0.01% |
579,252
+417,576
| +258% | +$859K |
|
2877
Alignment Healthcare
ALHC
$4.02B
| $820K | ﹤0.01% |
+46,535
| New | +$935K |
|
2878
SmartRent
SMRT
$183M
| $800K | ﹤0.01% |
534,108
-261,760
| -33% | -$442K |
|
|
DOYU
2879
DouYu International Holdings
DOYU
$136M
| $794K | ﹤0.01% |
158,767
-3,892
| -2% | -$22.3K |
|
2880
BlackSky Technology
BKSY
$800M
| $789K | ﹤0.01% |
31,369
-183,779
| -85% | -$4.39M |
|
2881
Destination XL Group
DXLG
$34.7M
| $789K | ﹤0.01% |
1,547,857
-74,396
| -5% | -$47.8K |
|
2882
Archer Aviation
ACHR
$3.64B
| $785K | ﹤0.01% |
+151,858
| New | +$1.08M |
|
|
CTNM
2883
Contineum Therapeutics
CTNM
$526M
| $782K | ﹤0.01% |
+59,946
| New | +$804K |
|
2884
Ginkgo Bioworks
DNA
$481M
| $779K | ﹤0.01% |
127,048
+24,434
| +24% | +$203K |
|
2885
Atlantic American Corp
AAME
$32M
| $772K | ﹤0.01% |
331,411
-699
| -0.2% | -$1.9K |
|
2886
Ark Restaurants
ARKR
| $769K | ﹤0.01% |
117,162
-5,035
| -4% | -$34K |
|
2887
Identive
INVE
$64.6M
| $768K | ﹤0.01% |
207,764
-902
| -0.4% | -$3.04K |
|
|
AEVA
2888
Aeva Technologies
AEVA
$1.02B
| $760K | ﹤0.01% |
58,112
-28,567
| -33% | -$425K |
|
2889
Transact Technologies
TACT
$51.7M
| $752K | ﹤0.01% |
228,704
-47,193
| -17% | -$170K |
|
2890
Biote Corp
BTMD
$69.2M
| $734K | ﹤0.01% |
543,494
-24,039
| -4% | -$48.3K |
|
2891
Nkarta
NKTX
$162M
| $731K | ﹤0.01% |
346,593
+147,894
| +74% | +$331K |
|
2892
Immunome
IMNM
$2.52B
| $731K | ﹤0.01% |
33,408
-282,975
| -89% | -$6.3M |
|
2893
MacroGenics
MGNX
$235M
| $727K | ﹤0.01% |
251,803
+64,028
| +34% | +$137K |
|
2894
908 Devices
MASS
$293M
| $726K | ﹤0.01% |
118,751
-127,863
| -52% | -$801K |
|
2895
Ceragon Networks
CRNT
$194M
| $722K | ﹤0.01% |
334,370
-6,178
| -2% | -$14K |
|
|
VBNK
2896
VersaBank
VBNK
$639M
| $721K | ﹤0.01% |
50,912
| – | – |
|
|
UPB
2897
Upstream Bio Inc
UPB
$349M
| $719K | ﹤0.01% |
+80,002
| New | +$1.44M |
|
|
CLYM
2898
Climb Bio
CLYM
$735M
| $715K | ﹤0.01% |
+104,437
| New | +$602K |
|
2899
WIX.com
WIX
$2.15B
| $708K | ﹤0.01% |
7,860
-991
| -11% | -$82.9K |
|
2900
Fossil Group
FOSL
$239M
| $702K | ﹤0.01% |
163,035
+10,399
| +7% | +$42K |
|
Similar funds
Dimensional Fund Advisors's Q1 2026 Portfolio in Review
As of Q1 2026, Dimensional Fund Advisors held 3,312 positions worth $481B, up 0.98% from $477B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Dimensional Fund Advisors's Q1 2026 filing shows 72 new, 1,935 increased, 1,135 reduced and 97 closed positions. Its largest new stake was Versant Media Group: 1,127,961 shares worth $41.7M. The largest sale was AstraZeneca, an estimated $609M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q1 2026 buy was Versant Media Group: 1,127,961 shares worth $41.7M.
- Dimensional Fund Advisors added most to Amazon in Q1 2026, an estimated $1.61B increase.
- Dimensional Fund Advisors's biggest Q1 2026 reduction was Johnson & Johnson, cutting an estimated $331M.
- Dimensional Fund Advisors fully exited AstraZeneca in Q1 2026, selling an estimated $609M.
- Dimensional Fund Advisors's ten largest holdings make up 17% of its $481B portfolio in Q1 2026.
- Dimensional Fund Advisors opened 72 new positions and closed 97 in Q1 2026.
- Dimensional Fund Advisors's portfolio value rose 0.98% quarter-over-quarter to $481B.
Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.